Capital BioVentures

Happy Holidays from all of us at #CBV. 2025 is going to be a big year for #biotech in Canada, and we can’t wait to be a part of the journey! #BigThingsComing #Innovation #Collaboration

Meet Darryl Davis at #RESIJPM. Learn more at our booth, or by speaking with our friends at Capital BioVentures and OBIO: Julia Pomoransky (Rintoul), Jose L. RodriguezJ and Jack Lee.

#CBV is proud to spotlight one of its seven companies enrolled in the biotech accelerator program, NuvoBio. NuvoBio is at the forefront of peptide therapeutics, leading the way with its innovative drug discovery platform, DarwinAI. With the growing demand for advanced treatments due to the rise in chronic diseases, NuvoBio's cutting-edge approach is transforming the landscape of drug development. Their ground-breaking methods not only accelerate the discovery process but also expand the potential of druggable targets while minimizing off-target risks. NuvoBio’s diverse pipeline of novel peptide therapeutics, backed by demonstrated proof of concept, is setting the stage for safer and more effective treatments. The company is focused on growth and development, with clinical trials anticipated in 2027, which will demonstrate advancements enabled by DarwinAI driven drug discovery. In the next year, they plan to expand on their business development and marketing strategy, through participation in scientific events and venture conferences. This will increase their visibility and strategic partnerships, positioning them as a leader in AI-driven peptide discovery. Meet the NuvoBio team at the upcoming JP Morgan Healthcare Conference in January! #innovation #Ottawa #healthcare #biotech

Thank you to the University of Ottawa and Intellectual Property Ontario (IPON) for inviting our Co-Founder and Executive Director, Dr. Jeff Smirle, to speak about #CBV at their Ideas to Impact event today at Invest Ottawa! It was great to engage with so many talented entrepreneurs and ecosystem builders! We are here to help accelerate your #biotech journey in #Ottawa #Collaboration #Innovation

#CBV is proud to announce the inaugural cohort for its Biotech Accelerator Program. Congratulations to NuvoBio, Rhythm Biotherapeutics Inc., Yellowbird Diagnostics, Inc. Esphera SynBio Inc, Hylid Diagnostics Inc, Virano Therapeutics and JN Nova. These seven visionary companies have been selected to receive unparalleled support, including consulting services, lab space placements, and non-dilutive funding. Thanks to funding from the Government of Canada through the Federal Economic Development Agency for Southern Ontario | Agence fédérale de ... (FedDev), CBV is working to address critical gaps in Ottawa's biotech ecosystem. Read the full press release to learn more about the selected companies and the impact it will have on the Ottawa biotech scene. https://lnkd.in/gjymnwCS

📢 Calling all #biotech companies! SCN is partnering with Mitacs to offer internships to the brightest graduate students and postdocs in #RegenerativeMedicine and biotech. The program aims to pair top talent with innovative Canadian companies focused on advancing stem cell-based therapies. Companies interested in hosting an intern for an 8-month internship starting between August 2025 and January 2026 are invited to submit an expression of interest. 🖇️ https://lnkd.in/eDXpgPeZ --- 📢 Appel à toutes les entreprises #biotechnologiques! Le RCS s’associe à Mitacs pour offrir des stages aux plus brillants étudiants diplômés et postdoctorants en #MédecineRégénératrice et en biotechnologie. Le programme vise à jumeler les meilleurs talents avec des entreprises canadiennes innovantes qui développent des thérapies à base de cellules souches. Les entreprises qui souhaitent accueillir un·e stagiaire pour un stage de 8 mois débutant entre le mois d’août 2025 et le mois de janvier 2026 sont invitées à soumettre une déclaration d’intérêt. 🖇️ https://lnkd.in/e4mr42a8

A big congratulations to #CBV portfolio companies NuvoBio, Rhythm Biotherapeutics Inc., Yellowbird Diagnostics, Inc., and Esphera SynBio Inc, along with all the companies selected in the first wave to present at the OBIO Investment Summit! We can’t wait to see you all on stage in February!

We’re excited to be here at the CHEO Research Institute #CoreInnovation Bear’s Den Pitch Event. Congratulations to all of the pitch finalists and to the CHEO team for putting on an amazing event! #Innovation #Healthcare #Ottawa

I was honoured to join our friends and institutional partner, Carleton University, for their announcement with the Queensway Carleton Hospital of the first new University based nursing program in over 20 years. The innovative curriculum, concentrations in mental health and data science, and focus on practitioner well-being will prepare graduates for an ever-changing healthcare practice and allow them to hit the ground running. #Ottawa and #Ontario will reap the benefit. This is a foundational move into healthcare for Carleton, and we are proud to call you a partner at Capital BioVentures Congratulations Maria DeRosa, Danielle Manley, Yvonne Wilson, and the entire team that put this together! #Innovation #Healthcare https://lnkd.in/gf5tU9Ep

We're #hiring a new Sensor Scientist in Ottawa, Ontario. Apply today or share this post with your network.